ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

38.36
Delayed Data
As of Apr 24
 -0.54 / -1.39%
Today’s Change
17.15
Today|||52-Week Range
46.48
+20.82%
Year-to-Date

Today’s Trading

Previous close38.90
Today’s open38.79
Day’s range38.02 - 39.00
Volume1,214,754
Average volume (3 months)2,116,657
Market cap$3.8B
Dividend yield--
Data as of 3:59pm ET, 04/24/2015

Growth & Valuation

Earnings growth (last year)-115.91%
Earnings growth (this year)-14.08%
Earnings growth (next 5 years)--
Revenue growth (last year)-89.52%
P/E ratioNM
Price/Sales25,730.20
Price/Book12.40

Competitors

 Today’s
change
Today’s
% change
NBIXNeurocrine Bioscienc...-0.31-0.71%
IPXLImpax Laboratories I...-0.53-1.06%
GRFSGrifols SA+0.32+0.95%
ASPXAuspex Pharmaceutica...-0.01-0.01%
Data as of 3:59pm ET, 04/24/2015

Financials

Next reporting dateMay 5, 2015
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$120.0K
Annual profit (last year)-$92.5M
Net profit margin-77,062.50%

Profile

Sector
Health Technology
Industry
Biotechnology
CEO, CFO, Chief Business Officer &
Executive VP
Stephen R. Davis
Chief Medical Officer &
Executive VP-Development
Roger M. Mills
Corporate headquarters
San Diego, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers